South African firm Biovac has struck a deal with Pfizer and BioNTech to produce their joint COVID-19 vaccine beginning in 2022. Pfizer and the South African government have been on opposite sides of a debate over waiving IP protections for COVID-19 vaccines during the pandemic to ease mass vaccination in the Third World.
